| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/03/2013 | US20130005668 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 01/03/2013 | US20130005666 Reporter system for high throughput screening of compounds and uses thereof |
| 01/03/2013 | US20130005651 Death associated protein 1 variants and use thereof for modulating autophagy |
| 01/03/2013 | US20130005590 Synthetic biology tools |
| 01/03/2013 | US20130005039 Thermoresponsive substrate with microgels, method for its preparation and culture method for biological cells |
| 01/03/2013 | US20130005038 Method of Separating Cells and Separation Apparatus |
| 01/03/2013 | US20130005037 Method of treating myocardial injury |
| 01/03/2013 | US20130005036 Manufacturing process for fresh and frozen stem cells |
| 01/03/2013 | US20130005035 Methods for generating t lymphocytes from hematopoietic stem cells |
| 01/03/2013 | US20130005034 Artificial peptide and use thereof |
| 01/03/2013 | US20130005033 Antibodies to human il-22 |
| 01/03/2013 | US20130005032 Apparatus and method for processing biological material |
| 01/03/2013 | US20130005031 Apparatus and method for processing biological material |
| 01/03/2013 | US20130005030 Gas57 mutant antigens and gas57 antibodies |
| 01/03/2013 | US20130005029 Ts-23 alpha-amylase variants with altered properties |
| 01/03/2013 | US20130005012 Enzymatic system for monomer synthesis |
| 01/03/2013 | US20130004995 Beta 1,3-n-acetyl-d-galactosamine transferase protein, nucleic acid encoding the same and method of examining canceration using the same |
| 01/03/2013 | US20130004992 Cells deficient in cmp-n-acetylneuraminic acid hydroxylase and/or glycoprotein alpha-1,3-galactosyltransferase |
| 01/03/2013 | US20130004985 Methods and compositions for treating neurological disorders |
| 01/03/2013 | US20130004984 Neuronal stimulation |
| 01/03/2013 | US20130004983 Compositions and methods for enhancing odorant receptor activity |
| 01/03/2013 | US20130004962 Method for evaluating cell aging by expression level of cofilin |
| 01/03/2013 | US20130004961 Methods of detecting a sweet-sensitive cell |
| 01/03/2013 | US20130004938 System and method for automated extraction of multi-cellular physiological parameters |
| 01/03/2013 | US20130004937 System for extended storage of red blood cells and methods of use |
| 01/03/2013 | US20130004936 Supercooling promoting agent |
| 01/03/2013 | US20130004584 Anti-inflammatory, radioprotective, and longevity enhancing capabilities of ceriumoxide nanoparticles |
| 01/03/2013 | US20130004581 Controlling uptake by cells |
| 01/03/2013 | US20130004543 Fibronectin: growth factor chimeras |
| 01/03/2013 | US20130004529 Vaccines and methods for using the same |
| 01/03/2013 | US20130004517 Disc-1 pathway activators in the control of neurogenesis |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004509 BRAF Mutations Conferring Resistance to BRAF Inhibitors |
| 01/03/2013 | US20130004508 Engineered anti-tslp antibody |
| 01/03/2013 | US20130004501 Human il-23 antigen binding proteins |
| 01/03/2013 | US20130004500 Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004499 Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/03/2013 | US20130004493 Epithelial membrane protein-2 (emp2) and proliferative vitroretinopathy (pvr) |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004488 Anti-cancer agent delivery vehicles capable of improved loading |
| 01/03/2013 | US20130004484 Anti-c-met antibody formulations |
| 01/03/2013 | US20130004472 Means and methods for improving the development and maturation of eggs and/or sperm in fish using hormones produced by transplanted cells |
| 01/03/2013 | US20130004471 Gene therapy vectors for adrenoleukodystrophy and adrenomyeloneuropathy |
| 01/03/2013 | US20130004470 p27 AND p21 IN GENE THERAPIES |
| 01/03/2013 | US20130004469 Engineered lumenized vascular networks and support matrix |
| 01/03/2013 | US20130004468 Methods of expanding myeloid cell populations and uses thereof |
| 01/03/2013 | US20130004467 Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells |
| 01/03/2013 | US20130004466 Myogenic differentiation of stem cells and and uses thereof |
| 01/03/2013 | US20130004465 Adherent cells from placenta and use of same in disease treatment |
| 01/03/2013 | US20130004464 Multipotent adult stem cell population |
| 01/03/2013 | US20130004462 Modified factor viii and factor ix genes and vectors for gene therapy |
| 01/03/2013 | US20130004432 Monoclonal antibodies that bind b7h6 and uses thereof |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004416 Dual Variable Domain Immunoglobulin and Uses Thereof |
| 01/03/2013 | DE10114189B4 Verfahren zur Gewinnung von Wertstoffen aus Organismen durch Beeinflussung/Beeinträchtigung der zelleigenen Transportsysteme für diese Wertstoffe bzw. durch Verwendung von Produktionsstämmen, denen besagte Transportsysteme fehlen Process for the recovery of valuable materials from organisms by affecting / impairment of cell-specific transport systems for these valuable materials or by the use of production strains, which said transport systems are missing |
| 01/03/2013 | CA2847292A1 Compositions and methods for enhancing bioenergetic status in female germ cells |
| 01/03/2013 | CA2840568A1 Compositions, uses, and preparation of platelet lysates |
| 01/03/2013 | CA2840525A1 Modified plants with increased oil content |
| 01/03/2013 | CA2840090A1 System and method for collagen isolation |
| 01/03/2013 | CA2840066A1 Signatures and determinants associated with prostate cancer progression and methods of use thereof |
| 01/03/2013 | CA2839938A1 Photoactivatable receptors and their uses |
| 01/03/2013 | CA2839663A1 Receptor gene for peptide cancer antigen-specific t cell |
| 01/02/2013 | EP2540822A1 Method for identification of oncogene, method for establishment of cell capable of expressing oncogene, and method for screening for oncogene-targeting substance |
| 01/02/2013 | EP2540821A1 Method for producing regulatory dendritic cells |
| 01/02/2013 | EP2540820A1 Means and methods for influencing the stability of antibody producing cells |
| 01/02/2013 | EP2540819A1 Method for cultivating cells in platelet-lysate-containing medium |
| 01/02/2013 | EP2540815A1 Perfusion cell culture |
| 01/02/2013 | EP2540313A1 Adaptation of pitman moore strain of rabies virus to primary chick embryo fibroblast cell cultures |
| 01/02/2013 | EP2539443A1 Methods and compositions for enhancing fat graft survival |
| 01/02/2013 | EP2539442A1 Method for the generation of a cik cell and nk cell population |
| 01/02/2013 | EP2539441A1 Cell culture medium for the growth and differentiation of cells of the hematopoietic lineage |
| 01/02/2013 | EP2539440A2 Derivation of hematopoietic cells from adult mesenchymal stem cells |
| 01/02/2013 | EP2539439A1 Modulation of angiogenesis |
| 01/02/2013 | EP2539438A1 Methods for preparing human melanocytes from human pluripotent stem cells |
| 01/02/2013 | EP2539437A2 SMOOTH MUSCLE-LIKE CELLS (SMLCs) DERIVED FROM HUMAN PLURIPOTENT STEM CELLS |
| 01/02/2013 | EP2539436A1 Modulation of macrophage activation |
| 01/02/2013 | EP2539435A2 Modified substrates for protection of peptide-immobilized surfaces from gamma radiation degradation |
| 01/02/2013 | EP2539434A1 Gametes separation methods, compositions and uses thereof |
| 01/02/2013 | EP2538988A2 Methods for tissue decellularization |
| 01/02/2013 | EP2538980A1 Cross-linking agents for hydrogels that contain cleavable peptides and short-chain polymers |
| 01/02/2013 | EP2538770A2 Melon plants comprising tetra-cis-lycopene |
| 01/02/2013 | EP1598422B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants |
| 01/02/2013 | CN202643702U Biphase porous three-dimensional cell culture support |
| 01/02/2013 | CN1854157B Antibodies to insulin-like growth factor i receptor |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102858997A Methods for monitoring cellular states and for immortalizing mesenchymal stem cells |
| 01/02/2013 | CN102858977A Antibody against serotype g lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858976A Antibody against serotype b lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858975A Antibody against serotype a lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858974A Antibody against serotype e lipopolysaccharide of pseudomonas aeruginosa |
| 01/02/2013 | CN102858970A Compositions and methods comprising variant proteases |
| 01/02/2013 | CN102858958A Induced Hepatic Stem Cell And Process For Production Thereof, And Applications Of The Cell |
| 01/02/2013 | CN102858957A Implant composition for the regeneration of neural tissue, process of preparation and uses thereof |
| 01/02/2013 | CN102858956A Modulation of angiogenesis |
| 01/02/2013 | CN102858955A Methods for preparing human melanocytes from human pluripotent stem cells |
| 01/02/2013 | CN102858954A Improved cell cultivation process |
| 01/02/2013 | CN102858953A 改进的细胞培养基 Improved cell culture medium |
| 01/02/2013 | CN102858952A 改进的细胞培养基 Improved cell culture medium |
| 01/02/2013 | CN102858951A Pluripotent stem cell that can be isolated from body tissue |
| 01/02/2013 | CN102858799A Antibody against serotype i lipopolysaccharide of pseudomonas aeruginosa |